Last 12 months
Inside the activity.
0 purchase rows · 64 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 5 |
| Dec 2025 | 0 | 5 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 26 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 6 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 4 |
| Aug 2026 | 0 | 10 |
| Sep 2026 | 0 | 5 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 11, 2019 Filed Feb 13, 2019 22:40 UTC |
Hill Scott AChief Financial Officer
|
Tax withholdingCommon Stock | 5,091 | $75.25 | $383,097.75 |
DisclosureSEC source: 0001209191-19-009802 · doc4.xml · nonDerivative · entry 2 Hill Scott A · CIK 0001397778 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,924 F3 · shares: Represents shares of common stock underlying vested restricted stock units that are being withheld to satisfy payment of the Issuer's tax withholding obligation. F4 · balance_after: The common stock number referred in Table I is an aggregate number and represents 127,360 shares of common stock and 62,564 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2019 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020 and will be reported at the time of vesting. The satisfaction of the 2017, 2018 and 2019 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020, February 2021, and February 2022, respectively, and will be reported at the time of vesting. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 22:40 UTC |
Hill Scott AChief Financial Officer
|
GrantCommon Stock | 33,693 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-009802 · doc4.xml · nonDerivative · entry 1 Hill Scott A · CIK 0001397778 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 195,015 F1 · shares: Represents shares of performance based restricted stock units granted to the filing person on February 8, 2018. The vesting of the shares of performance based restricted stock units was conditioned upon the achievement of certain 2018 earnings before interest, taxes, depreciation, and amortization ("EBITDA") performance versus pre-established targets. The restricted stock units vest over three years (1/3 on February 11, 2019, 1/3 on February 11, 2020 and 1/3 on February 11, 2021). Of the 33,693 shares, 11,231 shares were issued on February 11, 2019, of which 5,091 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The remaining 22,462 shares are scheduled to be issued on the two remaining vesting dates and taxes for these future issuances will be withheld and reported at the time the shares are issued. F2 · balance_after: Amount of securities beneficially owned includes 199 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on December 31, 2018. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 22:37 UTC |
Vice Charles AVice Chairman
|
Tax withholdingCommon Stock | 7,209 | $75.25 | $542,477.25 |
DisclosureSEC source: 0001209191-19-009795 · doc4.xml · nonDerivative · entry 2 Vice Charles A · CIK 0001343884 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 425,670 F2 · shares: Represents shares of common stock underlying vested restricted stock units that are being withheld to satisfy payment of the Issuer's tax withholding obligation. F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 335,588 shares of common stock and 90,082 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2019 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020 and will be reported at the time of vesting. The satisfaction of the 2017, 2018 and 2019 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020, February 2021 and February 2022, respectively, and will be reported at the time of vesting. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 22:37 UTC |
Vice Charles AVice Chairman
|
GrantCommon Stock | 47,773 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-009795 · doc4.xml · nonDerivative · entry 1 Vice Charles A · CIK 0001343884 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 432,879 F1 · shares: Represents shares of performance based restricted stock units granted to the filing person on February 8, 2018. The vesting of the shares of performance based restricted stock units was conditioned upon the achievement of certain 2018 earnings before interest, taxes, depreciation, and amortization ("EBITDA") performance versus pre-established targets. The restricted stock units vest over three years (1/3 on February 11, 2019, 1/3 on February 11, 2020 and 1/3 on February 11, 2021). Of the 47,773 shares, 15,924 shares were issued on February 11, 2019, of which 7,209 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The remaining 31,849 shares are scheduled to be issued on the two remaining vesting dates and taxes for these future issuances will be withheld and reported at the time the shares are issued. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 22:36 UTC |
Surdykowski Andrew JGeneral Counsel
|
Tax withholdingCommon Stock | 606 | $75.25 | $45,601.50 |
DisclosureSEC source: 0001209191-19-009790 · doc4.xml · nonDerivative · entry 2 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,147 F2 · shares: Represents shares of common stock underlying vested restricted stock units that are being withheld to satisfy payment of the Issuer's tax withholding obligation. F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 33,150 shares of common stock and 10,997 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2019 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020 and will be reported at the time of vesting. The satisfaction of the 2017, 2018 and 2019 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020, February 2021 and February 2022, respectively, and will be reported at the time of vesting. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 22:36 UTC |
Surdykowski Andrew JGeneral Counsel
|
GrantCommon Stock | 6,034 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-009790 · doc4.xml · nonDerivative · entry 1 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,753 F1 · shares: Represents shares of performance based restricted stock units granted to the filing person on February 8, 2018. The vesting of the shares of performance based restricted stock units was conditioned upon the achievement of certain 2018 earnings before interest, taxes, depreciation, and amortization ("EBITDA") performance versus pre-established targets. The restricted stock units vest over three years (1/3 on February 11, 2019, 1/3 on February 11, 2020 and 1/3 on February 11, 2021). Of the 6,034 shares, 2,011 shares were issued on February 11, 2019, of which 606 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The remaining 4,023 shares are scheduled to be issued on the two remaining vesting dates and taxes for these future issuances will be withheld and reported at the time the shares are issued. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 22:36 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 16,537 | $75.25 | $1,244,409.25 |
DisclosureSEC source: 0001209191-19-009788 · doc4.xml · nonDerivative · entry 2 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,571,359 F3 · shares: Represents shares of common stock underlying vested restricted stock units that are being withheld to satisfy payment of the Issuer's tax withholding obligation. F4 · balance_after: The common stock number referred in Table I is an aggregate number and represents 1,385,236 shares of common stock and 186,123 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2019 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020 and will be reported at the time of vesting. The satisfaction of the 2017, 2018 and 2019 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020, February 2021 and February 2022, respectively, and will be reported at the time of vesting. F5 · balance_after: As previously reported, the reporting person also indirectly owns 3,711,705 shares that are beneficially owned directly by CPEX. The reporting person beneficially owns 100% of the equity interest in CPEX. Additionally, as previously reported, the reporting person indirectly owns shares that are beneficially owned directly by the reporting person's spouse for which the reporting person disclaims beneficial ownership. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 22:36 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
GrantCommon Stock | 108,118 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-009788 · doc4.xml · nonDerivative · entry 1 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,587,896 F1 · shares: Represents shares of performance based restricted stock units granted to the filing person on February 8, 2018. The vesting of the shares of performance based restricted stock units was conditioned upon the achievement of certain 2018 earnings before interest, taxes, depreciation, and amortization ("EBITDA") performance versus pre-established targets. The restricted stock units vest over three years (1/3 on February 11, 2019, 1/3 on February 11, 2020 and 1/3 on February 11, 2021). Of the 108,118 shares, 36,039 shares were issued on February 11, 2019, of which 16,537 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The remaining 72,079 shares are scheduled to be issued on the two remaining vesting dates and taxes for these future issuances will be withheld and reported at the time the shares are issued. F2 · balance_after: Amount of securities beneficially owned includes 199 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on December 31, 2018. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 22:26 UTC |
Martin Lynn CPresident & COO, ICE Data Serv
|
Tax withholdingCommon Stock | 2,400 | $75.25 | $180,600.00 |
DisclosureSEC source: 0001209191-19-009766 · doc4.xml · nonDerivative · entry 2 Martin Lynn C · CIK 0001754817 · President & COO, ICE Data Serv 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,201 F3 · shares: Represents shares of common stock underlying vested restricted stock units that are being withheld to satisfy payment of the Issuer's tax withholding obligation. F4 · balance_after: The common stock number referred in Table I is an aggregate number and represents 14,378 shares of common stock and 19,823 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2019 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020 and will be reported at the time of vesting. The satisfaction of the 2017, 2018 and 2019 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020, February 2021 and February 2022, respectively, and will be reported at the time of vesting. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 22:26 UTC |
Martin Lynn CPresident & COO, ICE Data Serv
|
GrantCommon Stock | 15,085 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-009766 · doc4.xml · nonDerivative · entry 1 Martin Lynn C · CIK 0001754817 · President & COO, ICE Data Serv 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,601 F1 · shares: Represents shares of performance based restricted stock units granted to the filing person on February 8, 2018. The vesting of the shares of performance based restricted stock units was conditioned upon the achievement of certain 2018 earnings before interest, taxes, depreciation, and amortization ("EBITDA") performance versus pre-established targets. The restricted stock units vest over three years (1/3 on February 11, 2019, 1/3 on February 11, 2020 and 1/3 on February 11, 2021). Of the 15,085 shares, 5,028 shares were issued on February 11, 2019, of which 2,400 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The remaining 10,057 shares are scheduled to be issued on the two remaining vesting dates and taxes for these future issuances will be withheld and reported at the time the shares are issued. F2 · balance_after: Amount of securities beneficially owned includes 199 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on December 31, 2018. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 22:24 UTC |
Jackson BenjaminPresident
|
Tax withholdingCommon Stock | 4,238 | $75.25 | $318,909.50 |
DisclosureSEC source: 0001209191-19-009759 · doc4.xml · nonDerivative · entry 2 Jackson Benjamin · CIK 0001722067 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,339 F3 · shares: Represents shares of common stock underlying vested restricted stock units that are being withheld to satisfy payment of the Issuer's tax withholding obligation. F4 · balance_after: The common stock number referred in Table I is an aggregate number and represents 48,545 shares of common stock, 6,313 unvested restricted stock units ("RSUs"), and 34,481 unvested performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and the PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2019 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020 and will be reported at the time of vesting. The satisfaction of the 2017, 2018 and 2019 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020, February 2021 and February 2022, respectively, and will be reported at the time of vesting. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 22:24 UTC |
Jackson BenjaminPresident
|
GrantCommon Stock | 27,657 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-009759 · doc4.xml · nonDerivative · entry 1 Jackson Benjamin · CIK 0001722067 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,577 F1 · shares: Represents shares of performance based restricted stock units granted to the filing person on February 8, 2018. The vesting of the shares of performance based restricted stock units was conditioned upon the achievement of certain 2018 earnings before interest, taxes, depreciation, and amortization ("EBITDA") performance versus pre-established targets. The restricted stock units vest over three years (1/3 on February 11, 2019, 1/3 on February 11, 2020 and 1/3 on February 11, 2021). Of the 27,657 shares, 9,219 shares were issued on February 11, 2019, of which 4,238 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The remaining 18,438 shares are scheduled to be issued on the two remaining vesting dates and taxes for these future issuances will be withheld and reported at the time the shares are issued. F2 · balance_after: Amount of securities beneficially owned includes 199 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on December 31, 2018. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 22:22 UTC |
Goone David SChief Strategic Officer
|
Tax withholdingCommon Stock | 4,143 | $75.25 | $311,760.75 |
DisclosureSEC source: 0001209191-19-009749 · doc4.xml · nonDerivative · entry 2 Goone David S · CIK 0001343869 · Chief Strategic Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 178,247 F2 · shares: Represents shares of common stock underlying vested restricted stock units that are being withheld to satisfy payment of the Issuer's tax withholding obligation. F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 126,683 shares of common stock and 51,564 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2019 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020 and will be reported at the time of vesting. The satisfaction of the 2017, 2018 and 2019 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020, February 2021 and February 2022, respectively, and will be reported at the time of vesting. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 22:22 UTC |
Goone David SChief Strategic Officer
|
GrantCommon Stock | 27,657 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-009749 · doc4.xml · nonDerivative · entry 1 Goone David S · CIK 0001343869 · Chief Strategic Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,390 F1 · shares: Represents shares of performance based restricted stock units granted to the filing person on February 8, 2018. The vesting of the shares of performance based restricted stock units was conditioned upon the achievement of certain 2018 earnings before interest, taxes, depreciation, and amortization ("EBITDA") performance versus pre-established targets. The restricted stock units vest over three years (1/3 on February 11, 2019, 1/3 on February 11, 2020 and 1/3 on February 11, 2021). Of the 27,657 shares, 9,219 shares were issued on February 11, 2019, of which 4,143 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The remaining 18,438 shares are scheduled to be issued on the two remaining vesting dates and taxes for these future issuances will be withheld and reported at the time the shares are issued. Read SEC document |
| February 08, 2019 Filed Feb 21, 2019 16:41 UTC |
Wassersug MarkChief Operating Officer
|
GrantEmployee Stock Option (right to buy) Holding · Derivative | 16,181 | $0.00 Strike: $76.16 | $0.00 |
DisclosureSEC source: 0001209191-19-012068 · doc4.xml · derivative · entry 2 Wassersug Mark · CIK 0001722544 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,181 Underlying: Common Stock · 16,181 shares Expires 2029-02-08 F4 · derivative.exercise_date: These options vest in accordance with the following schedule: 33.33% of the options vest on February 8, 2020, 33.33% of the options vest on February 8, 2021 and 33.33% of the options vest on February 8, 2022. Read SEC document |
| February 08, 2019 Filed Feb 21, 2019 21:40 UTC |
Surdykowski Andrew JGeneral Counsel
|
GrantEmployee Stock Option (right to buy) Holding · Derivative | 12,944 | $0.00 Strike: $76.16 | $0.00 |
DisclosureSEC source: 0001209191-19-012060 · doc4.xml · derivative · entry 2 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,944 Underlying: Common Stock · 12,944 shares Expires 2029-02-08 F3 · derivative.exercise_date: These options vest in accordance with the following schedule: 33.33% of the options vest on February 8, 2020, 33.33% of the options vest on February 8, 2021 and 33.33% of the options vest on February 8, 2022. Read SEC document |
| February 08, 2019 Filed Feb 21, 2019 21:40 UTC |
Vice Charles AVice Chairman
|
GrantEmployee Stock Option (right to buy) Holding · Derivative | 61,488 | $0.00 Strike: $76.16 | $0.00 |
DisclosureSEC source: 0001209191-19-012064 · doc4.xml · derivative · entry 2 Vice Charles A · CIK 0001343884 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,488 Underlying: Common Stock · 61,488 shares Expires 2029-02-08 F3 · derivative.exercise_date: These options vest in accordance with the following schedule: 33.33% of the options vest on February 8, 2020, 33.33% of the options vest on February 8, 2021 and 33.33% of the options vest on February 8, 2022. Read SEC document |
| February 08, 2019 Filed Feb 21, 2019 21:39 UTC |
Martin Lynn CPresident & COO, ICE Data Serv
|
GrantEmployee Stock Option (right to buy) Holding · Derivative | 19,417 | $0.00 Strike: $76.16 | $0.00 |
DisclosureSEC source: 0001209191-19-012056 · doc4.xml · derivative · entry 2 Martin Lynn C · CIK 0001754817 · President & COO, ICE Data Serv 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,417 Underlying: Common Stock · 19,417 shares Expires 2029-02-08 F3 · derivative.exercise_date: These options vest in accordance with the following schedule: 33.33% of the options vest on February 8, 2020, 33.33% of the options vest on February 8, 2021 and 33.33% of the options vest on February 8, 2022. Read SEC document |
| February 08, 2019 Filed Feb 21, 2019 21:38 UTC |
Sprecher Jeffrey CDirector · Chief Executive Officer
|
GrantEmployee Stock Option (right to buy) Holding · Derivative | 139,158 | $0.00 Strike: $76.16 | $0.00 |
DisclosureSEC source: 0001209191-19-012053 · doc4.xml · derivative · entry 7 Sprecher Jeffrey C · CIK 0001343882 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,158 Underlying: Common Stock · 139,158 shares Expires 2029-02-08 F13 · derivative.exercise_date: These options vest in accordance with the following schedule: 33.33% of the options vest on February 8, 2020, 33.33% of the options vest on February 8, 2021 and 33.33% of the options vest on February 8, 2022. Read SEC document |
| February 08, 2019 Filed Feb 21, 2019 21:38 UTC |
Jackson BenjaminPresident
|
GrantEmployee Stock Option (right to buy) Holding · Derivative | 35,598 | $0.00 Strike: $76.16 | $0.00 |
DisclosureSEC source: 0001209191-19-012050 · doc4.xml · derivative · entry 2 Jackson Benjamin · CIK 0001722067 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,598 Underlying: Common Stock · 35,598 shares Expires 2029-02-08 F3 · derivative.exercise_date: These options vest in accordance with the following schedule: 33.33% of the options vest on February 8, 2020, 33.33% of the options vest on February 8, 2021 and 33.33% of the options vest on February 8, 2022. Read SEC document |
| February 08, 2019 Filed Feb 21, 2019 21:37 UTC |
Hill Scott AChief Financial Officer
|
GrantEmployee Stock Option (right to buy) Holding · Derivative | 43,365 | $0.00 Strike: $76.16 | $0.00 |
DisclosureSEC source: 0001209191-19-012046 · doc4.xml · derivative · entry 2 Hill Scott A · CIK 0001397778 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,365 Underlying: Common Stock · 43,365 shares Expires 2029-02-08 F3 · derivative.exercise_date: These options vest in accordance with the following schedule: 33.33% of the options vest on February 8, 2020, 33.33% of the options vest on February 8, 2021 and 33.33% of the options vest on February 8, 2022. Read SEC document |
| February 08, 2019 Filed Feb 21, 2019 21:37 UTC |
Goone David SChief Strategic Officer
|
GrantEmployee Stock Option (right to buy) Holding · Derivative | 35,598 | $0.00 Strike: $76.16 | $0.00 |
DisclosureSEC source: 0001209191-19-012042 · doc4.xml · derivative · entry 2 Goone David S · CIK 0001343869 · Chief Strategic Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,598 Underlying: Common Stock · 35,598 shares Expires 2029-02-08 F3 · derivative.exercise_date: These options vest in accordance with the following schedule: 33.33% of the options vest on February 8, 2020, 33.33% of the options vest on February 8, 2021 and 33.33% of the options vest on February 8, 2022. Read SEC document |
| February 08, 2019 Filed Mar 5, 2019 16:29 UTC |
Namkung James WChief Accounting Officer
|
GrantCommon Stock | 1,641 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-016507 · doc4.xml · nonDerivative · entry 4 Namkung James W · CIK 0001729468 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,354 F4 · shares: Represents shares of restricted stock issued to the filing person on February 8, 2019. This award of restricted stock vests over three years (1/3 on each anniversary of the award date). F5 · balance_after: The common stock number referred in Table I is an aggregate number and represents 10,621 shares of common stock and 3,072 unvested restricted stock units ("RSUs"), and 4,661 unvested performance based restricted stock units ("PSU's"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2019 PSUs tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020 and will be reported at the time of vesting. The satisfaction of the 2017, 2018 and 2019 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020, February 2021 and February 2022, respectively, and will be reported at the time of vesting. Read SEC document |
| February 08, 2019 Filed Mar 5, 2019 16:29 UTC |
Namkung James WChief Accounting Officer
|
Tax withholdingCommon Stock | 150 | $76.16 | $11,424.00 |
DisclosureSEC source: 0001209191-19-016507 · doc4.xml · nonDerivative · entry 3 Namkung James W · CIK 0001729468 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,713 F3 · shares: Represents shares of restricted stock issued to the filing person on February 8, 2018. The restricted stock units vest over three years (1/3 on February 8, 2019, 1/3 on February 8, 2020 and 1/3 on February 8, 2021). Of the 1,492 shares, 497 shares were issued on February 8, 2019, of which 150 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The remaining 995 shares are scheduled to be issued on the two remaining vesting dates and taxes for these future issuances will be withheld and reported at the time the shares are issued. Read SEC document |
| February 05, 2019 Filed Feb 7, 2019 21:23 UTC |
Vice Charles AVice Chairman
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 35,000 | $0.00 Strike: $25.87 | $0.00 |
DisclosureSEC source: 0001209191-19-008063 · doc4.xml · derivative · entry 3 Vice Charles A · CIK 0001343884 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 35,000 shares Expires 2023-01-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options are fully vested. Read SEC document |
| February 05, 2019 Filed Feb 7, 2019 21:23 UTC |
Vice Charles AVice Chairman
|
SaleCommon Stock | 35,000 | $77.10 | $2,698,454.50 |
DisclosureSEC source: 0001209191-19-008063 · doc4.xml · nonDerivative · entry 2 Vice Charles A · CIK 0001343884 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 385,106 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · price: The price range for the aggregate amount sold by the direct holder is $76.89 - $77.39. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 326,873 shares of common stock and 58,233 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2018 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2019 and will be reported at the time of vesting. The satisfaction of the 2017 and 2018 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020 and February 2021, respectively, and will be reported at the time of vesting. Read SEC document |
| February 05, 2019 Filed Feb 7, 2019 21:23 UTC |
Vice Charles AVice Chairman
|
Exercise / conversionCommon Stock | 35,000 | $25.87 | $905,450.00 |
DisclosureSEC source: 0001209191-19-008063 · doc4.xml · nonDerivative · entry 1 Vice Charles A · CIK 0001343884 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 420,106 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. Read SEC document |
| January 28, 2019 Filed Jan 30, 2019 21:39 UTC |
Surdykowski Andrew JGeneral Counsel
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 2,500 | $0.00 Strike: $21.20 | $0.00 |
DisclosureSEC source: 0001209191-19-006015 · doc4.xml · derivative · entry 3 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,490 Underlying: Common Stock · 2,500 shares Expires 2019-12-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options are fully vested. Read SEC document |
| January 28, 2019 Filed Jan 30, 2019 21:39 UTC |
Surdykowski Andrew JGeneral Counsel
|
SaleCommon Stock | 2,500 | $75.42 | $188,558.75 |
DisclosureSEC source: 0001209191-19-006015 · doc4.xml · nonDerivative · entry 2 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,719 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F3 · price: The price range for the aggregate amount sold by the direct holder is $75.11 - $75.67. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F4 · balance_after: The common stock number referred in Table I is an aggregate number and represents 31,745 shares of common stock and 6,974 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2018 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2019 and will be reported at the time of vesting. The satisfaction of the 2017 and 2018 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020 and February 2021, respectively, and will be reported at the time of vesting. Read SEC document |
| January 28, 2019 Filed Jan 30, 2019 21:39 UTC |
Surdykowski Andrew JGeneral Counsel
|
Exercise / conversionCommon Stock | 2,500 | $21.20 | $53,000.00 |
DisclosureSEC source: 0001209191-19-006015 · doc4.xml · nonDerivative · entry 1 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,219 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · balance_after: Amount of securities beneficially owned includes 199 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on December 31, 2018. Read SEC document |
| January 18, 2019 Filed Mar 5, 2019 16:29 UTC |
Namkung James WChief Accounting Officer
|
Tax withholdingCommon Stock | 155 | $75.63 | $11,722.65 |
DisclosureSEC source: 0001209191-19-016507 · doc4.xml · nonDerivative · entry 2 Namkung James W · CIK 0001729468 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,863 F2 · shares: Represents shares of restricted stock issued to the filing person on January 18, 2017. The restricted stock units vest over three years (1/3 on January 18, 2018, 1/3 on January 18, 2019 and 1/3 on January 18, 2020). Of the 1,308 shares, 436 shares were issued on January 18, 2019, of which 155 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The remaining 436 shares are scheduled to be issued on January 18, 2020 and taxes for this issuance will be withheld and reported at the time of vesting. Read SEC document |
| January 14, 2019 Filed Mar 5, 2019 16:29 UTC |
Namkung James WChief Accounting Officer
|
Tax withholdingCommon Stock | 147 | $72.70 | $10,686.90 |
DisclosureSEC source: 0001209191-19-016507 · doc4.xml · nonDerivative · entry 1 Namkung James W · CIK 0001729468 · Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,018 F1 · shares: Represents shares of restricted stock issued to the filing person on January 14, 2016. The restricted stock units vest over three years (1/3 on January 14, 2017, 1/3 on January 14, 2018 and 1/3 on January 14, 2019). Of the 1,245 shares, 415 shares were issued on January 14, 2019, of which 147 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The third and final tranche of shares for this award have been issued. Read SEC document |
| January 04, 2019 Filed Jan 8, 2019 21:37 UTC |
Vice Charles AVice Chairman
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 35,000 | $0.00 Strike: $25.87 | $0.00 |
DisclosureSEC source: 0001209191-19-002797 · doc4.xml · derivative · entry 4 Vice Charles A · CIK 0001343884 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2023-01-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: These options are fully vested. Read SEC document |
| January 04, 2019 Filed Jan 8, 2019 21:37 UTC |
Vice Charles AVice Chairman
|
SaleCommon Stock | 26,000 | $75.50 | $1,963,031.20 |
DisclosureSEC source: 0001209191-19-002797 · doc4.xml · nonDerivative · entry 3 Vice Charles A · CIK 0001343884 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 385,106 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F4 · price: The price range for the aggregate amount sold by the direct holder is $75.05 - $75.86. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F5 · balance_after: The common stock number referred in Table I is an aggregate number and represents 326,873 shares of common stock and 58,233 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2018 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2019 and will be reported at the time of vesting. The satisfaction of the 2017 and 2018 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020 and February 2021, respectively, and will be reported at the time of vesting. Read SEC document |
| January 04, 2019 Filed Jan 8, 2019 21:37 UTC |
Vice Charles AVice Chairman
|
SaleCommon Stock | 9,000 | $74.56 | $671,067.90 |
DisclosureSEC source: 0001209191-19-002797 · doc4.xml · nonDerivative · entry 2 Vice Charles A · CIK 0001343884 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 411,106 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F3 · price: The price range for the aggregate amount sold by the direct holder is $74.04 - $75.02. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| January 04, 2019 Filed Jan 8, 2019 21:37 UTC |
Vice Charles AVice Chairman
|
Exercise / conversionCommon Stock | 35,000 | $25.87 | $905,450.00 |
DisclosureSEC source: 0001209191-19-002797 · doc4.xml · nonDerivative · entry 1 Vice Charles A · CIK 0001343884 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 420,106 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · balance_after: Amount of securities beneficially owned includes 199 shares acquired under the Intercontinental Exchange, Inc. Employee Stock Purchase Plan on December 31, 2018. Read SEC document |
| December 13, 2018 Filed Dec 17, 2018 21:36 UTC |
Jackson BenjaminPresident
|
Tax withholdingCommon Stock | 644 | $77.59 | $49,967.96 |
DisclosureSEC source: 0001209191-18-062949 · doc4.xml · nonDerivative · entry 1 Jackson Benjamin · CIK 0001722067 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,721 F1 · shares: Represents shares of restricted stock issued to the filing person on December 13, 2017. The restricted stock units vest over three years (1/3 on December 13, 2018, 1/3 on December 13, 2019 and 1/3 on December 13, 2020). Of the 4,256 shares, 1,418 shares were issued on December 13, 2018, of which 644 shares were withheld to satisfy payment of the Issuer's tax withholding obligation. The remaining 2,838 shares are scheduled to be issued on December 13, 2019 and December 13, 2020 and taxes for these issuances will be withheld and reported at the time of vesting. F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 43,365 shares of common stock and 6,313 unvested restricted stock units ("RSUs"), and 16,043 unvested performance based restricted stock units ("PSU's"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2018 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2019 and will be reported at the time of vesting. The satisfaction of the 2017 and 2018 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020 and February 2021, respectively, and will be reported at the time of vesting. Read SEC document |
| December 06, 2018 Filed Dec 6, 2018 21:39 UTC |
Surdykowski Andrew JGeneral Counsel
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 2,000 | $0.00 Strike: $22.50 | $0.00 |
DisclosureSEC source: 0001209191-18-061288 · doc4.xml · derivative · entry 3 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,960 Underlying: Common Stock · 2,000 shares Expires 2021-01-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options are fully vested. Read SEC document |
| December 06, 2018 Filed Dec 6, 2018 21:39 UTC |
Surdykowski Andrew JGeneral Counsel
|
GiftCommon Stock | 300 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-061288 · doc4.xml · nonDerivative · entry 2 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,520 F1 · shares: This transaction involved a gift of 300 shares of the issuer's common stock by the reporting person to a philanthropic organization. F2 · balance_after: The common stock number referred in Table I is an aggregate number and represents 31,546 shares of common stock and 6,974 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2018 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2019 and will be reported at the time of vesting. The satisfaction of the 2017 and 2018 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020 and February 2021, respectively, and will be reported at the time of vesting. Read SEC document |
| December 06, 2018 Filed Dec 6, 2018 21:39 UTC |
Surdykowski Andrew JGeneral Counsel
|
Exercise / conversionCommon Stock | 2,000 | $22.50 | $45,000.00 |
DisclosureSEC source: 0001209191-18-061288 · doc4.xml · nonDerivative · entry 1 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,820 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 04, 2018 Filed Dec 6, 2018 21:39 UTC |
Vice Charles AVice Chairman
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 27,545 | $0.00 Strike: $50.01 | $0.00 |
DisclosureSEC source: 0001209191-18-061287 · doc4.xml · derivative · entry 6 Vice Charles A · CIK 0001343884 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,845 Underlying: Common Stock · 27,545 shares Expires 2026-01-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options are fully vested. Read SEC document |
| December 04, 2018 Filed Dec 6, 2018 21:39 UTC |
Vice Charles AVice Chairman
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 7,455 | $0.00 Strike: $25.87 | $0.00 |
DisclosureSEC source: 0001209191-18-061287 · doc4.xml · derivative · entry 5 Vice Charles A · CIK 0001343884 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,000 Underlying: Common Stock · 7,455 shares Expires 2023-01-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: These options are fully vested. Read SEC document |
| December 04, 2018 Filed Dec 6, 2018 21:39 UTC |
Vice Charles AVice Chairman
|
SaleCommon Stock | 13,100 | $80.39 | $1,053,095.90 |
DisclosureSEC source: 0001209191-18-061287 · doc4.xml · nonDerivative · entry 4 Vice Charles A · CIK 0001343884 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 384,907 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F3 · price: The price range for the aggregate amount sold by the direct holder is $80.00 - $80.94. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F4 · balance_after: The common stock number referred in Table I is an aggregate number and represents 326,674 shares of common stock and 58,233 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2018 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2019 and will be reported at the time of vesting. The satisfaction of the 2017 and 2018 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020 and February 2021, respectively, and will be reported at the time of vesting. Read SEC document |
| December 04, 2018 Filed Dec 6, 2018 21:39 UTC |
Vice Charles AVice Chairman
|
SaleCommon Stock | 21,900 | $79.37 | $1,738,240.23 |
DisclosureSEC source: 0001209191-18-061287 · doc4.xml · nonDerivative · entry 3 Vice Charles A · CIK 0001343884 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 398,007 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · price: The price range for the aggregate amount sold by the direct holder is $78.99 - $79.99. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
| December 04, 2018 Filed Dec 6, 2018 21:39 UTC |
Vice Charles AVice Chairman
|
Exercise / conversionCommon Stock | 7,455 | $25.87 | $192,860.85 |
DisclosureSEC source: 0001209191-18-061287 · doc4.xml · nonDerivative · entry 2 Vice Charles A · CIK 0001343884 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 419,907 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. Read SEC document |
| December 04, 2018 Filed Dec 6, 2018 21:39 UTC |
Vice Charles AVice Chairman
|
Exercise / conversionCommon Stock | 27,545 | $50.01 | $1,377,525.45 |
DisclosureSEC source: 0001209191-18-061287 · doc4.xml · nonDerivative · entry 1 Vice Charles A · CIK 0001343884 · Vice Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 412,452 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. Read SEC document |
| November 26, 2018 Filed Nov 28, 2018 21:54 UTC |
Surdykowski Andrew JGeneral Counsel
|
SaleCommon Stock | 1,200 | $80.14 | $96,168.00 |
DisclosureSEC source: 0001209191-18-060118 · doc4.xml · nonDerivative · entry 1 Surdykowski Andrew J · CIK 0001755922 · General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,820 F1 · shares: The sales reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F2 · price: The price range for the aggregate amount sold by the direct holder is $79.51 - $80.45. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F3 · balance_after: The common stock number referred in Table I is an aggregate number and represents 29,846 shares of common stock and 6,974 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2018 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2019 and will be reported at the time of vesting. The satisfaction of the 2017 and 2018 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020 and February 2021, respectively, and will be reported at the time of vesting. Read SEC document |
| November 15, 2018 Filed Nov 16, 2018 16:32 UTC |
Wassersug MarkChief Operating Officer
|
Exercise / conversionEmployee Stock Option (right to buy) Holding · Derivative | 7,903 | $0.00 Strike: $41.59 | $0.00 |
DisclosureSEC source: 0001209191-18-058966 · doc4.xml · derivative · entry 5 Wassersug Mark · CIK 0001722544 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,860 Underlying: Common Stock · 7,903 shares Expires 2025-01-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: These options are fully vested. Read SEC document |
| November 15, 2018 Filed Nov 16, 2018 16:32 UTC |
Wassersug MarkChief Operating Officer
|
SaleCommon Stock | 2,049 | $80.03 | $163,985.36 |
DisclosureSEC source: 0001209191-18-058966 · doc4.xml · nonDerivative · entry 4 Wassersug Mark · CIK 0001722544 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,079 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F4 · price: The price range for the aggregate amount sold by the direct holder is $79.92 - $80.15. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. F5 · balance_after: The common stock number referred in Table I is an aggregate number and represents 17,915 shares of common stock and 11,164 unvested performance based restricted stock units, for which the performance period has been satisfied. These performance based restricted stock units vest over a three year period, in which 33.33% of the units vest each year. The satisfaction of the 2018 performance based restricted units tied to earnings before interest, taxes, depreciation, and amortization, ("EBITDA") and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2019 and will be reported at the time of vesting. The satisfaction of the 2017 and 2018 total shareholder return performance based restricted stock units and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2020 and February 2021, respectively, and will be reported at the time of vesting. Read SEC document |
| November 15, 2018 Filed Nov 16, 2018 16:32 UTC |
Wassersug MarkChief Operating Officer
|
SaleCommon Stock | 2,354 | $79.40 | $186,913.96 |
DisclosureSEC source: 0001209191-18-058966 · doc4.xml · nonDerivative · entry 3 Wassersug Mark · CIK 0001722544 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,128 F1 · shares: The transactions reported in this Form 4 were effected pursuant to a pre-arranged trading plan established in accordance with Rule 10b5-1 of the Securities Act of 1934, as amended. F3 · price: The price range for the aggregate amount sold by the direct holder is $78.91 - $79.90. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.